Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan · Delayed Price · Currency is TWD

16.70

+0.10 (0.60%)

At close: Aug 6, 2026

Daiken Biomedical Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	2,024	1,895	1,362	1,190	884.97
Revenue Growth	39.00%	39.10%	14.45%	34.52%	-
Gross Profit	1,261	1,206	856.22	813.76	613.3
Operating Income	313.6	288.21	148.92	204.15	112.44
Net Income	337.22	337.87	106.58	160.35	90.17
Earnings Per Share	0.47	0.51	0.24	0.71	0.58
EPS Growth	4.69%	110.95%	-66.34%	23.14%	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	5,433	2,236	1,140	287.07	243.71
Total Debt	117.58	118.37	2.27	276.58	136
Net Cash (Debt)	5,316	2,118	1,137	10.49	107.71
Net Cash Growth	346.57%	86.20%	10746.37%	-90.26%	-
Net Cash Per Share	7.38	3.17	2.59	0.05	0.69

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	299.74	272.59	51.75	105.21	41.58
Capital Expenditures	-0.39	-0.39	-1.25	-	-
Free Cash Flow	299.35	272.21	50.5	105.21	41.58
Free Cash Flow Growth	247.32%	439.02%	-52.00%	153.01%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	62.32%	63.62%	62.85%	68.36%	69.30%
Operating Margin	15.49%	15.21%	10.93%	17.15%	12.71%
Pretax Margin	21.08%	22.03%	10.25%	16.41%	12.38%
Profit Margin	16.66%	17.83%	7.82%	13.47%	10.19%
FCF Margin	14.79%	14.36%	3.71%	8.84%	4.70%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.698	0.698	0.404	0.486	0.417
Dividend Per Share Growth	0%	72.88%	-16.87%	16.55%	-
Dividend Yield	4.21%	4.08%	2.44%	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PE Ratio	35.65	43.03	101.90	-	-
Forward PE	-	34.13	-	-	-
P/FCF Ratio	45.19	53.42	215.06	-	-
PS Ratio	6.68	7.67	7.97	-	-